Lung injury in vivax malaria: Pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation

Journal of Infectious Diseases

Volumn 195, Issue 4, 2007, Pages 589-596

  Anstey, Nicholas M ^a   Handojo, Tjandra ^a   Pain, Michael C F ^b   Kenangalem, Enny ^b,d   Tjitra, Emiliana ^e   Price, Ric N ^a,f   Maguire, Graeme P ^a,c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Western Australia Country Health Service Kimberley   (Australia)

^d Ministry of Health   (Papua New Guinea)

^e NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DETERIORATION; ERYTHROCYTE; FEMALE; HUMAN; INDONESIA; LONGITUDINAL STUDY; LUNG ALVEOLUS; LUNG BLOOD VESSEL; LUNG CAPILLARY; LUNG GAS EXCHANGE; LUNG INJURY; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; OXYGEN SATURATION; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANIMALS; BLOOD GAS ANALYSIS; CAPILLARIES; ERYTHROCYTES; FEMALE; HUMANS; INDONESIA; LONGITUDINAL STUDIES; LUNG; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MIDDLE AGED; OXYGEN; PARASITEMIA; PLASMODIUM VIVAX; PULMONARY ALVEOLI; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS; RESPIRATORY MECHANICS;

EID: 33846819045     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510756     Document Type: Article

References (50)

1. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004; 4:327-36.
2. Price RN, Tjitia E, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg (in press).
3. Nosten F, McGready R, Simpson JA, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999; 354:546-9.
4. Chotinavich K, Udomsangpetch R, Pukrittayakamee S, et al. The adhesion receptors of P. vivax-infected red cells (abstract P27). Exp Parasitol 2003; 105:33-4.
5. McGready R, Davison BB, Stepniewska K, et al. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. Am J Trop Med Hyg 2004; 70:398-407.
6. Clark H, Tomlinson W. The pathologic anatomy of malaria. In: Boyd M, ed. Malariology. Philadelphia: WB Saunders, 1949:874-903.
7. Ewing J. Contribution to the pathological anatomy of malaria fever. J Exp Med 1902; 6:119-80.
8. Bruetsch W. The histopathology of therapeutic (tertian) malaria. Am J Psychiat 1932; 12:19-65.
9. Billings F, Post W. Fatal malaria due to the tertian parasite. Trans Chicago Path Soc 1915; 9:209-15.
10. Islam N, Qamruddin K. Unusual complications in benign tertian malaria. Trop Geogr Med 1995; 47:141-3.
11. Torres JR, Perez H, Postigo MM, Silva JR. Acute non-cardiogenic lung injury in benign tertian malaria. Lancet 1997; 350:31-2.
12. Munteis E, Mellibovsky L, Marquez MA, Minguez S, Vazquez E, Diez A. Pulmonary involvement in a case of Plasmodium vivax malaria. Chest 1997; 111:834-5.
13. Pukrittayakamee S, Chantra A, Vanijanonta S, White NJ. Pulmonary oedema in vivax malaria. Trans R Soc Trop Med Hyg 1998; 92:421-2.
14. Perren A, Beretta F, Schubarth P. [ARDS in Plasmodium vivax malaria]. Schweiz Med Wochenschr 1998; 128:1020-3.
15. Curlin ME, Barat LM, Walsh DK, Granger DL. Noncardiogenic pulmonary edema during vivax malaria. Clin Infect Dis 1999; 28:1166-7.
16. Carlini ME, White AC Jr, Atmar RL. Vivax malaria complicated by adult respiratory distress syndrome. Clin Infect Dis 1999; 28:1182-3.
17. Tanios MA, Kogelman L, McGovern B, Hassoun PM. Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit Care Med 2001; 29:665-7.
18. Lomar AV, Vidal JE, Lomar FP, Barbas CV, Matos GJ, Boulos M. Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz J Infect Dis 2005; 9:425-30.
19. Habib AG, Singh KS. Respiratory distress in nonimmune adults with imported malaria. Infection 2004; 32:356-9.
20. Lawn SD, Krishna S, Jarvis JN, Joet T, Macallan DC. Case reports: pernicious complications of benign tertian malaria. Trans R Soc Trop Med Hyg 2003; 97:551-3.
21. Saleri N, Gulletta M, Matteelli A, et al. Acute respiratory distress syndrome in Plasmodium vivax malaria in traveler returning from Venezuela. J Travel Med 2006; 13:112-3.
22. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax malaria. Emerg Infect Dis 2005; 11:132-4.
23. Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP. An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA 2005; 293:212-6.
24. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94 (Suppl 1):S1-90.
25. James MF. Pulmonary damage associated with falciparum malaria: a report of ten cases. Ann Trop Med Parasitol 1985; 79:123-38.
26. Brooks CMH, Kiel LCFW, Sheehy LCTW, Barry LCKG. Acute pulmonary edema in falciparum malaria. N Engl J Med 1968; 279:732-7.
27. Anstey NM, Jacups SP, Cain T, et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis 2002; 185:1326-34.
28. Roughton FJW, Forster RE. Relative importance of diffusion and chemical reaction in determining rate of exchange of gases in the human lung. J Appl Physiol 1957; 11:290-302.
29. Hughes JM, Bates DV Historical review: the carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell (Theta.Vc) components. Respir Physiol Neurobiol 2003; 138:115-42.
30. Ross R, Thomson D. Some enumartive studies on malaria fever. Proc Roy Soc 1911; 83:159-73.
31. Field J, Shute P. Plasmodium vivax. In: The microscopic diagnosis of human malaria. Vol. 2: a morphological study of the erythrocytic parasites. Kuala Lumpur: Institute for Medical Research, 1956.
32. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992; 89:3200-3.
33. Hemmer CJ, Holst FG, Kern P, Chiwakata CB, Dietrich M, Reisinger EC. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 2006; 11:817-23.
34. Maguire GP, Handojo T, Pain MC, et al. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia. J Infect Dis 2005; 192:1966-74.
35. Spitz S. The pathology of acute falciparum malaria. Mil Surg 1946:555-72.
36. Ratcliff A, Siswantoro H, Kenangalem E, et al. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans R Soc Trop Med Hyg (in press).
37. Handojo T, Anstey N, Kelly P, et al. Normal spirometry, gas transfer and lung volume values in Papua, Indonesia. Southeast Asian J Trop Med Public Health 2006; 37:571-7.
38. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-36.
39. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique - 1995 update. Am J Respir Crit Care Med 1995; 152:2185-98.
40. Coquelin F, Boulard Y, Mora-Silvera E, Richard F, Chabaud AG, Landau I. Final stage of maturation of the erythrocytic schizonts of rodent Plasmodium in the lungs. C R Acad Sci III 1999; 322:55-62.
41. Udomsangpetch R, Thanikkul K, Pukrittayakamee S, White NJ. Rosette formation by Plasmodium vivax. Trans R Soc Trop Med Hyg 1995; 89:635-7.
42. Robert C, Pouvelle B, Meyer P, et al. Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells. Res Immunol 1995; 146:383-93.
43. Traore B, Muanza K, Looareesuwan S, et al. Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model. Am J Trop Med Hyg 2000; 62:38-44.
44. Suwanarusk R, Cooke BM, Dondorp AM, et al. The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. J Infect Dis 2004; 189:190-4.
45. Steenhuis LH, Groen HJ, Koeter GH, van der Mark TW. Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J 2000; 16:276-81.
46. Bonay M, Bancal C, de Zuttere D, Arnoult F, Saumon G, Camus F. Normal pulmonary capillary blood volume in patients with chronic infiltrative lung disease and high pulmonary artery pressure. Chest 2004; 126:1460-6.
47. Puri S, Baker BL, Dutka DP, Oakley CM, Hughes JM, Cleland JG. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation 1995; 91:2769-74.
48. O'Dempsey TJ, McArdle TF, Laurence BE, Lamont AC, Todd JE, Greenwood BM. Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg 1993; 87:662-5.
49. Tjitra E. Improving the diagnosis and treatment of malaria in Eastern Indonesia [dissertation]. Menzies School of Health Research, Northern Territory University, Darwin, 2001:1-309.
50. World Health Organization (WHO). The overlap in the clinical presentation and treatment of malaria and pneumonia in children: report of a meeting. WHO/ARI/92.23. WHO, Geneva, 1992:1-14.